Back

Impact of leadless micra pacemaker on tricuspid regurgitation and clinical outcomes: a single-center experience

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Antibradycardia Pacing EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

213 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Prevalence of moderate or severe tricuspid regurgitation following leadless pacemaker implantation: a systematic review and single-arm meta-analysis
thumbnail
Congress Presentation
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: final results from the Micra AV Post-Approval Registry
thumbnail
Congress Presentation
Tricuspid regurgitation after cardiac device implantation: incidence and predictors in a prospective cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources